Skip to main content
Caplight Logo









Illumos Ltd.

Illumos Ltd.

Private
Hong KongHealthcare & Life Scienceshttps://illumos.co

Company Overview

Illumos Ltd. operates in Healthcare & Life Sciences and is based in Hong Kong. It was founded in 2023.

Illumos Ltd. is a biotechnology company that develops 3D tissue diagnostics and labelling reagents for medical research and clinical pathology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Imaging, Precision Medicine, Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Illumos Ltd. Comparables

Compare Illumos Ltd. with similar companies based on industry and business-model similarity.

Illumos Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
IMAI MedTech
85%
Alpenglow Biosciences
83%
ClearLight Biotechnologies
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Illumos Ltd. Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Illumos Ltd.. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Hei Ming LAI

Chief Executive Officer

Executive Team

Cathy Chan

Chief Operating Officer

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 8, 2026

    Monthly visitors increased 74% MoM.

  • Jul 6, 2025

    Monthly visitors grew 182% MoM, from 253 to 713.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • launchesSep 21, 2026

    Illumos Ltd. released an updated protocol for the standard OmniStain kit, now renamed OmniStain IMMUNO, using the same kit components and providing increased signal intensity.

Book a demo to see all news

For institutional investors. Book with your work email.

Illumos Ltd. Filings

Explore SEC and related filing metadata, where available.

Illumos Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Illumos Ltd.'s valuation, stock price, and market status.

Is Illumos Ltd. a public or private company?

Illumos Ltd. is a private company.

What is the current stock price of Illumos Ltd.?

Illumos Ltd. is a private company, so its shares have no public market price. Caplight tracks Illumos Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Illumos Ltd. worth (valuation)?

Valuation information for Illumos Ltd. is not publicly available.

Can I buy Illumos Ltd. stock?

Illumos Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Illumos Ltd.'s last funding round?

Funding round information for Illumos Ltd. is not publicly available.

Who are the main investors in Illumos Ltd.?

Investor information for Illumos Ltd. is not publicly disclosed.

Will Illumos Ltd. IPO soon?

No public IPO plans have been announced for Illumos Ltd..

How can I track Illumos Ltd. secondary market activity?

Caplight tracks bids, offers, and trades in Illumos Ltd.'s shares on secondary markets.

Firmographic Details

HeadquartersHong Kong
Employee Range6
Year Founded2023
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?